Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic Boosting of Olaparib to Improve Exposure, Tolerance and Cost-effectiveness

NCT05078671 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT05078671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05078671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic Boosting of Olaparib to Improve Exposure, Tolerance and Cost-effectiveness
Lead sponsor
Radboud University Medical Center
Phase
Phase 4
Overall status
Unknown status
Start date
December 15, 2021
Completion date
December 31, 2025
Enrollment
160 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

cancer